Fig. 7

Genipin suppresses proliferation of various non-HCC cancer cells. (a) Colon, gastric, ovarian, breast, prostate, cervix, and pancreas cancer cells were pretreated with genipin (20 and 50 μM). Living cells were detected by MTS assay after 36 h of incubation. (b) Various non-HCC cancer cells were pre-treated with genipin (20 and 50 μM) for 12 h. Expressions of p-STAT-3 and total STAT-3 were examined by western blot assay. Data presented as mean ± SD. **P < 0.01 and ***P < 0.001